Panzara Michael A. 4
4 · Wave Life Sciences Ltd. · Filed Jan 4, 2022
Insider Transaction Report
Form 4
Panzara Michael A.
Franchise Lead, Neurology
Transactions
- Award
Share Option (right to buy)
2022-01-01+200,000→ 200,000 totalExercise: $3.14Exp: 2032-01-01→ Ordinary Shares (200,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the shares on January 1, 2023 and vests as to an additional 6.25% of the shares quarterly thereafter until January 1, 2026.